Authors
Loading...
Early RAS activity assessment in mild mitral disease is feasible; leaves open prognostic or therapeutic relevance in human HF.
Key points are not available for this paper at this time.
Pedersen et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: